These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31472039)

  • 1. Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial.
    Takagi K; Blet A; Levy B; Deniau B; Azibani F; Feliot E; Bergmann A; Santos K; Hartmann O; Gayat E; Mebazaa A; Kimmoun A
    Eur J Heart Fail; 2020 Feb; 22(2):279-286. PubMed ID: 31472039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics.
    Deniau B; Rehfeld L; Santos K; Dienelt A; Azibani F; Sadoune M; Kounde PR; Samuel JL; Tolpannen H; Lassus J; Harjola VP; Vodovar N; Bergmann A; Hartmann O; Mebazaa A; Blet A
    Eur J Heart Fail; 2020 Feb; 22(2):290-299. PubMed ID: 31472040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study.
    Blet A; Deniau B; Santos K; van Lier DPT; Azibani F; Wittebole X; Chousterman BG; Gayat E; Hartmann O; Struck J; Bergmann A; Antonelli M; Beishuizen A; Constantin JM; Damoisel C; Deye N; Di Somma S; Dugernier T; François B; Gaudry S; Huberlant V; Lascarrou JB; Marx G; Mercier E; Oueslati H; Pickkers P; Sonneville R; Legrand M; Laterre PF; Mebazaa A;
    Crit Care; 2021 Feb; 25(1):61. PubMed ID: 33588925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes.
    Wenzl FA; Bruno F; Kraler S; Klingenberg R; Akhmedov A; Ministrini S; Santos K; Godly K; Godly J; Niederseer D; Manka R; Bergmann A; Camici GG; von Eckardstein A; Stähli B; Muller O; Roffi M; Räber L; Lüscher TF
    Eur Heart J; 2023 Oct; 44(38):3859-3871. PubMed ID: 37632743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl Amino-Peptidase 3 (DPP3) as an Early Marker of Severity in a Patient Population with Cardiogenic Shock.
    Innelli P; Lopizzo T; Paternò G; Bruno N; Radice RP; Bertini P; Marabotti A; Luzi G; Stabile E; Di Fazio A; Pittella G; Paternoster G
    Diagnostics (Basel); 2023 Apr; 13(7):. PubMed ID: 37046568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Circulating Dipeptidyl Peptidase 3 Predicts Mortality and Need for Organ Support in Cardiogenic Shock: An Ancillary Analysis of the ACCOST-HH Trial.
    Picod A; Nordin H; Jarczak D; Zeller T; Oddos C; Santos K; Hartmann O; Herpain A; Mebazaa A; Kluge S; Azibani F; Karakas M
    J Card Fail; 2024 Apr; ():. PubMed ID: 38697465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of bioactive adrenomedullin and dipeptidyl peptidase 3 to predict short-term unfavourable outcomes after cardiac surgery: A prospective cohort study.
    van Lier D; Beunders R; Kox M; Pickkers P
    Eur J Anaesthesiol; 2022 Apr; 39(4):342-351. PubMed ID: 35102040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.
    Levy B; Clere-Jehl R; Legras A; Morichau-Beauchant T; Leone M; Frederique G; Quenot JP; Kimmoun A; Cariou A; Lassus J; Harjola VP; Meziani F; Louis G; Rossignol P; Duarte K; Girerd N; Mebazaa A; Vignon P;
    J Am Coll Cardiol; 2018 Jul; 72(2):173-182. PubMed ID: 29976291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock:
    van Lier D; Picod A; Marx G; Laterre PF; Hartmann O; Knothe C; Azibani F; Struck J; Santos K; Zimmerman J; Bergmann A; Mebazaa A; Pickkers P
    Front Med (Lausanne); 2022; 9():1058235. PubMed ID: 36530868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of circulating dipeptidyl-peptidase 3 restores cardiac function in a sepsis-induced model in rats: A proof of concept study.
    Deniau B; Blet A; Santos K; Vaittinada Ayar P; Genest M; Kästorf M; Sadoune M; de Sousa Jorge A; Samuel JL; Vodovar N; Bergmann A; Mebazaa A; Azibani F
    PLoS One; 2020; 15(8):e0238039. PubMed ID: 32853284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-hospital mortality and organ failure after open and endovascular thoraco-abdominal aortic surgery can be predicted by increased levels of circulating dipeptidyl peptidase 3.
    Gombert A; Barbati M; Kotelis D; Simon TP; Breuer T; Hartmann O; Santos K; Bergmann D; Schulte J; Marx G; Jacobs M; Stoppe C
    Eur J Cardiothorac Surg; 2021 Apr; 59(4):750-757. PubMed ID: 33236058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating dipeptidyl peptidase-3 at admission is associated with circulatory failure, acute kidney injury and death in severely ill burn patients.
    Dépret F; Amzallag J; Pollina A; Fayolle-Pivot L; Coutrot M; Chaussard M; Santos K; Hartmann O; Jully M; Fratani A; Oueslati H; Cupaciu A; Benyamina M; Guillemet L; Deniau B; Mebazaa A; Gayat E; Farny B; Textoris J; Legrand M;
    Crit Care; 2020 Apr; 24(1):168. PubMed ID: 32321571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of dipeptidyl-peptidase 3 with short-term outcome in a mixed admission ICU-cohort.
    van Lier D; Beunders R; Kox M; Pickkers P
    J Crit Care; 2023 Dec; 78():154383. PubMed ID: 37482013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulatory dipeptidyl peptidase 3 (cDPP3) is a potential biomarker for early detection of secondary brain injury after aneurysmal subarachnoid hemorrhage.
    Neumaier F; Stoppe C; Veldeman M; Weiss M; Simon T; Hoellig A; Marx G; Clusmann H; Albanna W
    J Neurol Sci; 2021 Mar; 422():117333. PubMed ID: 33549902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma proenkephalin A 119-159 and dipeptidyl peptidase 3 on admission after cardiac arrest help predict long-term neurological outcome.
    Thorgeirsdóttir B; Levin H; Spångfors M; Annborn M; Cronberg T; Nielsen N; Lybeck A; Friberg H; Frigyesi A
    Resuscitation; 2021 Jun; 163():108-115. PubMed ID: 33930500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failure.
    Boorsma EM; Ter Maaten JM; Damman K; van Veldhuisen DJ; Dickstein K; Anker SD; Filippatos G; Lang CC; Metra M; Santos K; Voors AA
    Eur J Heart Fail; 2021 Jun; 23(6):947-953. PubMed ID: 33742751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.
    ; Alexander JH; Reynolds HR; Stebbins AL; Dzavik V; Harrington RA; Van de Werf F; Hochman JS
    JAMA; 2007 Apr; 297(15):1657-66. PubMed ID: 17387132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating dipeptidyl peptidase 3 on intensive care unit admission is a predictor of organ dysfunction and mortality.
    Frigyesi A; Lengquist M; Spångfors M; Annborn M; Cronberg T; Nielsen N; Levin H; Friberg H
    J Intensive Care; 2021 Aug; 9(1):52. PubMed ID: 34429159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Plasma Bioactive Adrenomedullin and Mortality in Cardiogenic Shock: Results from the OptimaCC Trial.
    Takagi K; Levy B; Kimmoun A; Miró Ò; Duarte K; Asakage A; Blet A; Deniau B; Schulte J; Hartmann O; Cotter G; Davison BA; Gayat E; Mebazaa A
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidyl peptidase 3, a biomarker in cardiogenic shock and hopefully much more.
    Magliocca A; Omland T; Latini R
    Eur J Heart Fail; 2020 Feb; 22(2):300-302. PubMed ID: 31840335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.